ArticleBMC rheumatology2022

Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy.

Amanda Lusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.